Acarix AB (publ) (ACIXF)

USD 0.02

(-4.78%)

EBITDA Summary of Acarix AB (publ)

Acarix AB (publ)'s latest annual EBITDA in 2023 was -74.61 Million SEK , down -1.13% from previous year.
Acarix AB (publ)'s latest quarterly EBITDA in 2024 Q2 was -15.82 Million SEK , down -11.64% from previous quarter.
Acarix AB (publ) reported an annual EBITDA of -73.78 Million SEK in 2022, down -52.82% from previous year.
Acarix AB (publ) reported an annual EBITDA of -48.28 Million SEK in 2021, down -27.09% from previous year.
Acarix AB (publ) reported a quarterly EBITDA of -15.82 Million SEK for 2024 Q2, down -11.64% from previous quarter.
Acarix AB (publ) reported a quarterly EBITDA of -15.64 Million SEK for 2023 Q1, up 29.44% from previous quarter.

Annual EBITDA Chart of Acarix AB (publ) (2023 - 2014)

Historical Annual EBITDA of Acarix AB (publ) (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	-74.61 Million SEK	-1.13%
2022	-73.78 Million SEK	-52.82%
2021	-48.28 Million SEK	-27.09%
2020	-37.99 Million SEK	17.72%
2019	-46.17 Million SEK	-9.25%
2018	-42.26 Million SEK	-38.25%
2017	-30.57 Million SEK	-15.32%
2016	-26.5 Million SEK	-73.85%
2015	-15.24 Million SEK	36.02%
2014	-23.83 Million SEK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-14.17 Million SEK	34.07%
2024 Q2	-15.82 Million SEK	-11.64%
2023 Q1	-15.64 Million SEK	29.44%
2023 Q3	-16.41 Million SEK	22.06%
2023 FY	- SEK	-1.13%
2023 Q4	-21.5 Million SEK	-31.0%
2023 Q2	-21.06 Million SEK	-34.62%
2022 Q3	-19.98 Million SEK	-13.29%
2022 FY	- SEK	-52.82%
2022 Q4	-22.17 Million SEK	-10.97%
2022 Q2	-17.63 Million SEK	-21.02%
2022 Q1	-14.57 Million SEK	9.51%
2021 Q4	-16.1 Million SEK	-63.31%
2021 Q3	-9.86 Million SEK	19.52%
2021 Q2	-12.25 Million SEK	-7.47%
2021 FY	- SEK	-27.09%
2021 Q1	-11.4 Million SEK	-10.11%
2020 Q3	-8.06 Million SEK	14.96%
2020 Q1	-10.36 Million SEK	-4.44%
2020 Q2	-9.48 Million SEK	8.5%
2020 FY	- SEK	17.72%
2020 Q4	-10.35 Million SEK	-28.36%
2019 Q3	-10.29 Million SEK	8.56%
2019 FY	- SEK	-9.25%
2019 Q4	-9.92 Million SEK	3.56%
2019 Q2	-11.25 Million SEK	11.81%
2019 Q1	-12.76 Million SEK	-5.3%
2018 Q2	-8.91 Million SEK	-11.91%
2018 Q3	-12.13 Million SEK	-36.09%
2018 Q4	-12.12 Million SEK	0.11%
2018 FY	- SEK	-38.25%
2018 Q1	-7.96 Million SEK	34.72%
2017 FY	- SEK	-15.32%
2017 Q2	-6.74 Million SEK	-74.65%
2017 Q3	-6.99 Million SEK	-3.66%
2017 Q4	-12.2 Million SEK	-74.56%
2017 Q1	-3.86 Million SEK	74.19%
2016 Q2	-2.39 Million SEK	-7.17%
2016 Q1	-2.23 Million SEK	1.15%
2016 Q4	-14.96 Million SEK	-116.07%
2016 Q3	-6.92 Million SEK	-189.75%
2016 FY	- SEK	-73.85%
2015 FY	- SEK	36.02%
2015 Q4	-2.25 Million SEK	0.0%
2014 FY	- SEK	0.0%

Peer EBITDA Comparison of Acarix AB (publ)

Name	EBITDA	EBITDA Difference
Healwell AI Inc.	-16.11 Million USD	-363.098%
Regional Health Properties, Inc.	1.11 Million USD	6774.329%